The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Endofluke 100 mg/ml Oral Suspension

Bimeda Animal Health LimitedVPA22033/060/001

Main Information

Trade NameEndofluke 100 mg/ml Oral Suspension
Active SubstancesTriclabendazole
Dosage FormOral suspension
Licence HolderBimeda Animal Health Limited
Licence NumberVPA22033/060/001

Group Information

ATC CodeQP52AC01 triclabendazole
Therapeutic ClassEndoparasiticide


License statusAuthorised
Licence Issued01/08/2002
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back